Phase III study showed Xofluza (baloxavir marboxil) is effective at preventing influenza infection
- Compared with placebo, Xofluza treatment significantly reduced the likelihood of people developing influenza (flu) after exposure to an infected household member
- Data from the phase III BLOCKSTONE study will be submitted to health authorities globally